- Conditions
- Temporal Hollowing
- Interventions
- Restylane Contour
- Device
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 225 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Encino, California • Los Angeles, California + 12 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 385–408
of 637
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole oral tablets 500mg, 1% SPL7013 Gel, Placebo gel
- Drug
- Lead sponsor
- Starpharma Pty Ltd
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 637 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • San Diego, California • Metairie, Louisiana + 1 more
- Conditions
- Wound of Skin
- Interventions
- Normal Saline and Amorphous gel, BIAKOS™ Antimicrobial Skin & Wound Cleanser, BIAKŌS Antimicrobial Wound Gel
- Device
- Lead sponsor
- SerenaGroup, Inc.
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Lavior Diabetic Wound Gel, Smith & Nephew Solosite Gel Hydrogel Wound Dressing
- Drug
- Lead sponsor
- Lavior Pharma Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Madarosis, Hypotrichosis
- Interventions
- Bimatoprost eyelash gel
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 80 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Nasolabial Folds
- Interventions
- Radiesse® Injectable Dermal Filler Mixed with Lidocaine, Radiesse® Injectable Dermal Filler without Lidocaine
- Device
- Lead sponsor
- Merz North America, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- Rockville, Maryland • New York, New York
- Conditions
- Pelvic Floor Disorders
- Interventions
- 2% lidocaine gel, Water based lubricant
- Drug
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Rosacea
- Interventions
- Metronidazole Topical Gel 1%, Metronidazole Topical Gel 1% (Metrogel), Placebo
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 602 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 22
- States / cities
- Phoenix, Arizona • Long Beach, California • Newport Beach, California + 19 more
- Conditions
- Molluscum Contagiosum
- Interventions
- SB206 12%, Placebo
- Drug
- Lead sponsor
- Novan, Inc.
- Industry
- Eligibility
- 6 Months and older
- Enrollment
- 352 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 35
- States / cities
- Mobile, Alabama • Glendale, Arizona • Little Rock, Arkansas + 32 more
- Conditions
- Acne Vulgaris, Acne
- Interventions
- CT Gel, Clindamycin Gel (clindamycin ), Tretinoin Gel (tretinoin), Vehicle Gel
- Drug
- Lead sponsor
- Stiefel, a GSK Company
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 1,649 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Hot Springs, Arkansas + 24 more
- Conditions
- Diabetic Foot Ulcer
- Interventions
- 0.75% MDI-1228_mesylate gel plus Standard of Care, Standard of Care Alone
- Drug · Other
- Lead sponsor
- Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Lateral Canthal Lines, Crow's Feet, Facial Wrinkles
- Interventions
- Botulinum Toxin Type A, Placebo
- Drug
- Lead sponsor
- Revance Therapeutics, Inc.
- Industry
- Eligibility
- 30 Years to 60 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Kidney Stones
- Interventions
- BackStop
- Device
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Virginia Beach, Virginia
- Conditions
- Pain, Aging
- Interventions
- RHA® Redensity with new anesthetic agent, RHA® Redensity with lidocaine
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • New York, New York
- Conditions
- Postdural Puncture Headache
- Interventions
- Sphenopalatine Ganglion Block, Placebo
- Procedure
- Lead sponsor
- University of Arkansas
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Little Rock, Arkansas
- Conditions
- Actinic Keratosis
- Interventions
- PEP005 (ingenol mebutate) Gel
- Drug
- Lead sponsor
- Peplin
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Paramus, New Jersey
- Conditions
- Breast Cancer, Cognitive Side Effects of Cancer Treatments, Stage I, II and III A Breast Cancer
- Interventions
- Questionnaires, MRI, Comet assay and Cell senescence
- Behavioral
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 53 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2021
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Nasolabial Folds, Wrinkles
- Interventions
- TEOSYAL® RHA Ultra Deep
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 4
- States / cities
- Beverly Hills, California • Bradenton, Florida • Chapel Hill, North Carolina + 1 more
- Conditions
- HIV Infections
- Interventions
- UC-781 microbicide gel (0.1% and 0.25%), placebo
- Drug
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Healthy
- Interventions
- Ambrotose LIFE, Advanced Ambrotose, Placebo
- Dietary Supplement · Other
- Lead sponsor
- University of Memphis
- Other
- Eligibility
- 20 Years to 65 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Acne Vulgaris
- Interventions
- Onexton, Clindamycin/benzoyl peroxide gel, Placebo
- Drug
- Lead sponsor
- Actavis Inc.
- Industry
- Eligibility
- 12 Years to 40 Years
- Enrollment
- 862 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Chula Vista, California • La Mesa, California + 14 more
- Conditions
- Infantile Hemangioma, Very Low Birth Weight Infants
- Interventions
- topical 0.5% Timolol maleate, Control (placebo) group
- Drug
- Lead sponsor
- Alice K. Gong
- Other
- Eligibility
- Up to 6 Months
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Healthy
- Interventions
- Silver Nanoparticle Gel, alcohol-based hand gel
- Drug
- Lead sponsor
- Madigan Army Medical Center
- Federal
- Eligibility
- 19 Years and older
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Tacoma, Washington
- Conditions
- Papulopustular Rosacea
- Interventions
- omiganan, placebo
- Drug
- Lead sponsor
- Maruho Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 240 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2013
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Santa Monica, California • New Haven, Connecticut + 14 more